B. Riley Issues Positive Estimate for Altimmune Earnings
Altimmune, Inc. (NASDAQ:ALT – Free Report) – B. Riley upped their Q2 2025 earnings estimates for Altimmune in a note issued to investors on Wednesday, May 14th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings of ($0.26) per share for the quarter, up from their prior forecast of ($0.27). The […]
Altimmune, Inc. (NASDAQ:ALT – Free Report) – B. Riley upped their Q2 2025 earnings estimates for Altimmune in a note issued to investors on Wednesday, May 14th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings of ($0.26) per share for the quarter, up from their prior forecast of ($0.27). The […]
